This hour features unrelated updates across health and markets, with no single throughline emerging. In health, discourse addressed the potential of specific gut microbes and the difficulty of discontinuing long-term medications. Meanwhile, economic reports highlighted market caution, focusing on investor anxiety over a potential artificial intelligence bubble linked to SK Hynix and the disconnect between falling raw cocoa costs and stubbornly high retail chocolate prices.